Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Erratum

Erratum to: EVOTECH®endoscope cleaner and reprocessor (ECR) simulated-use and clinical-use evaluation of cleaning efficacy

Authors: Michelle J Alfa, Pat DeGagne, Nancy Olson, Iram Fatima

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Excerpt

The original submission of this manuscript included a citation of one of the authors' patents [1]. During the review process, we were alerted to the existence of another relevant patent. As is the norm, it was our intention that all references to any patents should be removed from the manuscript and replaced by the relevant original peer reviewed research. Unfortunately, the authors were not asked to do this and the manuscript was inadvertently published with the patent citation included. …
Metadata
Title
Erratum to: EVOTECH®endoscope cleaner and reprocessor (ECR) simulated-use and clinical-use evaluation of cleaning efficacy
Authors
Michelle J Alfa
Pat DeGagne
Nancy Olson
Iram Fatima
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-291

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine